Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1974 3
1977 3
1978 2
1979 1
1981 2
1984 2
1987 3
1989 1
1991 1
1992 3
1993 7
1995 4
1996 1
1997 1
1998 2
1999 3
2000 3
2001 3
2002 3
2003 5
2004 2
2005 4
2006 1
2007 1
2009 8
2010 8
2011 7
2012 6
2013 2
2014 4
2015 9
2016 4
2017 7
2018 9
2019 9
2020 19
2021 11
2022 11
2023 16
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for adam feed
Search for Adam Fheed instead (1 results)
Beckwith-Wiedemann Syndrome.
Shuman C, Kalish JM, Weksberg R. Shuman C, et al. 2000 Mar 3 [updated 2023 Sep 21]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. 2000 Mar 3 [updated 2023 Sep 21]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. PMID: 20301568 Free Books & Documents. Review.
Non-tumor surveillance includes measurement of growth parameters, assessment for signs/symptoms of sleep apnea, and monitoring of developmental progress / educational needs at each visit; pre-feed serum glucose level per endocrinologist recommendations in neonates and infa …
Non-tumor surveillance includes measurement of growth parameters, assessment for signs/symptoms of sleep apnea, and monitoring of developmen …
Christianson Syndrome.
Morrow EM, Pescosolido MF. Morrow EM, et al. 2018 Jan 11. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. 2018 Jan 11. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. PMID: 29334451 Free Books & Documents. Review.
Subsequently, regression (e.g., loss of ambulation and ability to feed independently) may occur. Manifestations in heterozygous females range from asymptomatic to mild ID and/or behavioral issues. ...
Subsequently, regression (e.g., loss of ambulation and ability to feed independently) may occur. Manifestations in heterozygous femal …
Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome.
Camacho J, Rioseco-Camacho N. Camacho J, et al. 2012 May 31 [updated 2020 Feb 13]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. 2012 May 31 [updated 2020 Feb 13]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. PMID: 22649802 Free Books & Documents. Review.
Manifestations of hyperammonemia usually begin 24-48 hours after feeding begins and can include lethargy, somnolence, refusal to feed, vomiting, tachypnea with respiratory alkalosis, and/or seizures. ...
Manifestations of hyperammonemia usually begin 24-48 hours after feeding begins and can include lethargy, somnolence, refusal to feed …
KCNQ3-Related Disorders.
Miceli F, Soldovieri MV, Weckhuysen S, Cooper EC, Taglialatela M. Miceli F, et al. 2014 May 22 [updated 2023 Sep 28]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. 2014 May 22 [updated 2023 Sep 28]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. PMID: 24851285 Free Books & Documents. Review.
Motor activity may be confined to one body part, migrate to other regions, or generalize. Infants are normal between seizures and feed normally. In KCNQ3-SLFIE, seizures start in the first year of life beyond the neonatal period and disappear after age one to two years. .. …
Motor activity may be confined to one body part, migrate to other regions, or generalize. Infants are normal between seizures and feed …
Argininosuccinate Lyase Deficiency.
Nagamani SCS, Erez A, Lee B. Nagamani SCS, et al. 2011 Feb 3 [updated 2019 Mar 28]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. 2011 Feb 3 [updated 2019 Mar 28]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. PMID: 21290785 Free Books & Documents. Review.
CLINICAL CHARACTERISTICS: Deficiency of argininosuccinate lyase (ASL), the enzyme that cleaves argininosuccinic acid to produce arginine and fumarate in the fourth step of the urea cycle, may present as a severe neonatal-onset form or a late-onset form: The severe neonatal-onset …
CLINICAL CHARACTERISTICS: Deficiency of argininosuccinate lyase (ASL), the enzyme that cleaves argininosuccinic acid to produce arginine and …
Zellweger Spectrum Disorder.
Steinberg SJ, Raymond GV, Braverman NE, Moser AB. Steinberg SJ, et al. 2003 Dec 12 [updated 2020 Oct 29]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. 2003 Dec 12 [updated 2020 Oct 29]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. PMID: 20301621 Free Books & Documents. Review.
Individuals with ZSD usually come to clinical attention in the newborn period or later in childhood. Affected newborns are hypotonic and feed poorly. They have distinctive facies, congenital malformations (neuronal migration defects associated with neonatal-onset seizures, …
Individuals with ZSD usually come to clinical attention in the newborn period or later in childhood. Affected newborns are hypotonic and …
Anti-parasitic activity of polyether ionophores.
Antoszczak M, Steverding D, Huczyński A. Antoszczak M, et al. Eur J Med Chem. 2019 Mar 15;166:32-47. doi: 10.1016/j.ejmech.2019.01.035. Epub 2019 Jan 17. Eur J Med Chem. 2019. PMID: 30684869 Review.
Polyether ionophore antibiotics (ionophores), traditionally used in veterinary medicine as anti-coccidial feed additives and non-hormonal growth promoters, are of considerable interest, as they have been found to be highly effective agents against various parasites, both i …
Polyether ionophore antibiotics (ionophores), traditionally used in veterinary medicine as anti-coccidial feed additives and non-horm …
Citrullinemia Type I.
Quinonez SC, Lee KN. Quinonez SC, et al. 2004 Jul 7 [updated 2022 Aug 18]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. 2004 Jul 7 [updated 2022 Aug 18]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. PMID: 20301631 Free Books & Documents. Review.
Shortly thereafter, they develop hyperammonemia and become progressively lethargic, feed poorly, often vomit, and may develop signs of increased intracranial pressure (ICP). ...
Shortly thereafter, they develop hyperammonemia and become progressively lethargic, feed poorly, often vomit, and may develop signs o …
Patentology of chitinous biomaterials. Part I: Chitin.
Kertmen A, Ehrlich H. Kertmen A, et al. Carbohydr Polym. 2022 Apr 15;282:119102. doi: 10.1016/j.carbpol.2022.119102. Epub 2022 Jan 10. Carbohydr Polym. 2022. PMID: 35123756 Review.
Such directions as biomedicine, materials science and engineering, chemistry and biochemistry, biotechnology, pharmaceutics, cosmetics, food and feed additives, agriculture as well as environmental science are considered. ...
Such directions as biomedicine, materials science and engineering, chemistry and biochemistry, biotechnology, pharmaceutics, cosmetics, food …
Prokinetic drugs for feed intolerance in critical illness: current and potential therapies.
Deane AM, Fraser RJ, Chapman MJ. Deane AM, et al. Crit Care Resusc. 2009 Jun;11(2):132-43. Crit Care Resusc. 2009. PMID: 19485878 Review.
Recent research has improved our understanding of the complex abnormalities of gastric motor function that underlie delayed gastric emptying in the critically ill. Feed intolerance can be treated with prokinetic drugs and/or by the placement of postpyloric feeding catheter …
Recent research has improved our understanding of the complex abnormalities of gastric motor function that underlie delayed gastric emptying …
170 results